Submit Search
Upload
Rutherford slide
•
1 like
•
350 views
Marilyn Mann
Follow
Trial of a PCSK9 inhibitor in heterozygous familial hypercholesterolemia
Read less
Read more
Health & Medicine
Report
Share
Report
Share
1 of 1
Download now
Download to read offline
Recommended
Immunotherapy in type 1 Diabetes
Immunotherapy in type 1 Diabetes
Dr Karthik Balachandran
Lonafarnib by aseem
Lonafarnib by aseem
Dr. Aseem Sharma
Estimation of serum protein Dr. saba
Estimation of serum protein Dr. saba
Saba Khan
New Treatments for Severe Hypercholesteremia
New Treatments for Severe Hypercholesteremia
Allina Health
PCSK9 Inhibitors PP
PCSK9 Inhibitors PP
Vince Netto
Linagliptin Endocrinologist Prespective - Case.pptx
Linagliptin Endocrinologist Prespective - Case.pptx
AmeetRathod3
Evolocumab in hyperlipidemia
Evolocumab in hyperlipidemia
niteshpansari
Diabetic dyslipidemia and Saroglitazar
Diabetic dyslipidemia and Saroglitazar
Dr Vivek Baliga
Recommended
Immunotherapy in type 1 Diabetes
Immunotherapy in type 1 Diabetes
Dr Karthik Balachandran
Lonafarnib by aseem
Lonafarnib by aseem
Dr. Aseem Sharma
Estimation of serum protein Dr. saba
Estimation of serum protein Dr. saba
Saba Khan
New Treatments for Severe Hypercholesteremia
New Treatments for Severe Hypercholesteremia
Allina Health
PCSK9 Inhibitors PP
PCSK9 Inhibitors PP
Vince Netto
Linagliptin Endocrinologist Prespective - Case.pptx
Linagliptin Endocrinologist Prespective - Case.pptx
AmeetRathod3
Evolocumab in hyperlipidemia
Evolocumab in hyperlipidemia
niteshpansari
Diabetic dyslipidemia and Saroglitazar
Diabetic dyslipidemia and Saroglitazar
Dr Vivek Baliga
Target ldl levels in extreme high risk acs. acheiving the goal
Target ldl levels in extreme high risk acs. acheiving the goal
Dr MD TALHA KHAN ABID
Design and Synthesis of some Pyrimidine as DPP-IV Inhibitors
Design and Synthesis of some Pyrimidine as DPP-IV Inhibitors
mohd imran Ahmad
UPDATE ON THE PCKS9 INHIBITION TO LOWER LDL CHOLESTEROL
UPDATE ON THE PCKS9 INHIBITION TO LOWER LDL CHOLESTEROL
Praveen Nagula
DIABETES Y ENFERMEDAD CARDIOVASCULAR 23NOVIEMBRE18
DIABETES Y ENFERMEDAD CARDIOVASCULAR 23NOVIEMBRE18
CRISTOBAL MORALES PORTILLO
PCSK9 Inhibitors
PCSK9 Inhibitors
Terri Newman
Novel approaches in Lipid Management
Novel approaches in Lipid Management
Shashikiran Umakanth
Dr. Tinahones - Simposio lanzamiento alirocumab
Dr. Tinahones - Simposio lanzamiento alirocumab
Campus Sanofi
New microsoft power point presentation
New microsoft power point presentation
Dr Bikash Chandra Paul
Recent advances in dyslipidemia
Recent advances in dyslipidemia
Seth GSMC and KEM Municipal Hospital
Linagliptin Endocrinologist Prespective - Case.pptx
Linagliptin Endocrinologist Prespective - Case.pptx
AmeetRathod3
Linagliptin in DKD.pptx
Linagliptin in DKD.pptx
AmeetRathod3
Sglt 2 inhibiors in cardiovascular diseases
Sglt 2 inhibiors in cardiovascular diseases
Yogesh Shilimkar
Acute complications of diabetes mellitus
Acute complications of diabetes mellitus
Gofasefer
Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...
Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...
Marilyn Mann
Clinical trail drug
Clinical trail drug
AlFahadUlIslam1
Ueda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayed
ueda2015
Case study-metabolic-syndrome-myerson
Case study-metabolic-syndrome-myerson
Deb Wolf
Following the Evidence: LDL-C as a Path to Reducing Cardiovascular Events—How...
Following the Evidence: LDL-C as a Path to Reducing Cardiovascular Events—How...
PVI, PeerView Institute for Medical Education
Ueda2016 new horizon in the management of dyslipidemia - diaa ewais
Ueda2016 new horizon in the management of dyslipidemia - diaa ewais
ueda2015
Resultados de la inhibición de PCSK9: superando los límites
Resultados de la inhibición de PCSK9: superando los límites
Sociedad Española de Cardiología
Comparative effectiveness randomized trial to improve stroke care delivery c...
Comparative effectiveness randomized trial to improve stroke care delivery c...
Marilyn Mann
Marilyn mann slides for qcor 2018 final
Marilyn mann slides for qcor 2018 final
Marilyn Mann
More Related Content
Similar to Rutherford slide
Target ldl levels in extreme high risk acs. acheiving the goal
Target ldl levels in extreme high risk acs. acheiving the goal
Dr MD TALHA KHAN ABID
Design and Synthesis of some Pyrimidine as DPP-IV Inhibitors
Design and Synthesis of some Pyrimidine as DPP-IV Inhibitors
mohd imran Ahmad
UPDATE ON THE PCKS9 INHIBITION TO LOWER LDL CHOLESTEROL
UPDATE ON THE PCKS9 INHIBITION TO LOWER LDL CHOLESTEROL
Praveen Nagula
DIABETES Y ENFERMEDAD CARDIOVASCULAR 23NOVIEMBRE18
DIABETES Y ENFERMEDAD CARDIOVASCULAR 23NOVIEMBRE18
CRISTOBAL MORALES PORTILLO
PCSK9 Inhibitors
PCSK9 Inhibitors
Terri Newman
Novel approaches in Lipid Management
Novel approaches in Lipid Management
Shashikiran Umakanth
Dr. Tinahones - Simposio lanzamiento alirocumab
Dr. Tinahones - Simposio lanzamiento alirocumab
Campus Sanofi
New microsoft power point presentation
New microsoft power point presentation
Dr Bikash Chandra Paul
Recent advances in dyslipidemia
Recent advances in dyslipidemia
Seth GSMC and KEM Municipal Hospital
Linagliptin Endocrinologist Prespective - Case.pptx
Linagliptin Endocrinologist Prespective - Case.pptx
AmeetRathod3
Linagliptin in DKD.pptx
Linagliptin in DKD.pptx
AmeetRathod3
Sglt 2 inhibiors in cardiovascular diseases
Sglt 2 inhibiors in cardiovascular diseases
Yogesh Shilimkar
Acute complications of diabetes mellitus
Acute complications of diabetes mellitus
Gofasefer
Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...
Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...
Marilyn Mann
Clinical trail drug
Clinical trail drug
AlFahadUlIslam1
Ueda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayed
ueda2015
Case study-metabolic-syndrome-myerson
Case study-metabolic-syndrome-myerson
Deb Wolf
Following the Evidence: LDL-C as a Path to Reducing Cardiovascular Events—How...
Following the Evidence: LDL-C as a Path to Reducing Cardiovascular Events—How...
PVI, PeerView Institute for Medical Education
Ueda2016 new horizon in the management of dyslipidemia - diaa ewais
Ueda2016 new horizon in the management of dyslipidemia - diaa ewais
ueda2015
Resultados de la inhibición de PCSK9: superando los límites
Resultados de la inhibición de PCSK9: superando los límites
Sociedad Española de Cardiología
Similar to Rutherford slide
(20)
Target ldl levels in extreme high risk acs. acheiving the goal
Target ldl levels in extreme high risk acs. acheiving the goal
Design and Synthesis of some Pyrimidine as DPP-IV Inhibitors
Design and Synthesis of some Pyrimidine as DPP-IV Inhibitors
UPDATE ON THE PCKS9 INHIBITION TO LOWER LDL CHOLESTEROL
UPDATE ON THE PCKS9 INHIBITION TO LOWER LDL CHOLESTEROL
DIABETES Y ENFERMEDAD CARDIOVASCULAR 23NOVIEMBRE18
DIABETES Y ENFERMEDAD CARDIOVASCULAR 23NOVIEMBRE18
PCSK9 Inhibitors
PCSK9 Inhibitors
Novel approaches in Lipid Management
Novel approaches in Lipid Management
Dr. Tinahones - Simposio lanzamiento alirocumab
Dr. Tinahones - Simposio lanzamiento alirocumab
New microsoft power point presentation
New microsoft power point presentation
Recent advances in dyslipidemia
Recent advances in dyslipidemia
Linagliptin Endocrinologist Prespective - Case.pptx
Linagliptin Endocrinologist Prespective - Case.pptx
Linagliptin in DKD.pptx
Linagliptin in DKD.pptx
Sglt 2 inhibiors in cardiovascular diseases
Sglt 2 inhibiors in cardiovascular diseases
Acute complications of diabetes mellitus
Acute complications of diabetes mellitus
Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...
Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...
Clinical trail drug
Clinical trail drug
Ueda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayed
Case study-metabolic-syndrome-myerson
Case study-metabolic-syndrome-myerson
Following the Evidence: LDL-C as a Path to Reducing Cardiovascular Events—How...
Following the Evidence: LDL-C as a Path to Reducing Cardiovascular Events—How...
Ueda2016 new horizon in the management of dyslipidemia - diaa ewais
Ueda2016 new horizon in the management of dyslipidemia - diaa ewais
Resultados de la inhibición de PCSK9: superando los límites
Resultados de la inhibición de PCSK9: superando los límites
More from Marilyn Mann
Comparative effectiveness randomized trial to improve stroke care delivery c...
Comparative effectiveness randomized trial to improve stroke care delivery c...
Marilyn Mann
Marilyn mann slides for qcor 2018 final
Marilyn mann slides for qcor 2018 final
Marilyn Mann
ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACS
ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACS
Marilyn Mann
Patient Viewpoint on PCSK9 Inhibitors
Patient Viewpoint on PCSK9 Inhibitors
Marilyn Mann
2016 hope 3 cognitive outcomes slides
2016 hope 3 cognitive outcomes slides
Marilyn Mann
Pcsk9 loss of-function genetic variant is associated with pre-diabetes and di...
Pcsk9 loss of-function genetic variant is associated with pre-diabetes and di...
Marilyn Mann
Alirocumab effect on new-onset or worsening diabetes, blood glucose, and HbA1c.
Alirocumab effect on new-onset or worsening diabetes, blood glucose, and HbA1c.
Marilyn Mann
Complaint in hdl v johnson and dent
Complaint in hdl v johnson and dent
Marilyn Mann
Center Scope Fall 2014
Center Scope Fall 2014
Marilyn Mann
Improve it slides
Improve it slides
Marilyn Mann
Circ cardiovasc qual outcomes 2013 sep 6(5) 507 8, figure
Circ cardiovasc qual outcomes 2013 sep 6(5) 507 8, figure
Marilyn Mann
Ph rma principlesforresponsibleclinicaltrialdatasharing
Ph rma principlesforresponsibleclinicaltrialdatasharing
Marilyn Mann
Ema q & a on mipomersen march 2013
Ema q & a on mipomersen march 2013
Marilyn Mann
Ema scientific conclusions and grounds for refusal of mipomersen
Ema scientific conclusions and grounds for refusal of mipomersen
Marilyn Mann
Oxman et al a surrealistic mega analysis of redisorganization theories
Oxman et al a surrealistic mega analysis of redisorganization theories
Marilyn Mann
Glasziou taking healthcare interventions from trial to practice
Glasziou taking healthcare interventions from trial to practice
Marilyn Mann
Ioannidis why science is not necessarily self correcting
Ioannidis why science is not necessarily self correcting
Marilyn Mann
Cer symposium 2012_ioannidis
Cer symposium 2012_ioannidis
Marilyn Mann
Ema q & a on mipomersen
Ema q & a on mipomersen
Marilyn Mann
Involveconference2 121120053215-phpapp02
Involveconference2 121120053215-phpapp02
Marilyn Mann
More from Marilyn Mann
(20)
Comparative effectiveness randomized trial to improve stroke care delivery c...
Comparative effectiveness randomized trial to improve stroke care delivery c...
Marilyn mann slides for qcor 2018 final
Marilyn mann slides for qcor 2018 final
ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACS
ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACS
Patient Viewpoint on PCSK9 Inhibitors
Patient Viewpoint on PCSK9 Inhibitors
2016 hope 3 cognitive outcomes slides
2016 hope 3 cognitive outcomes slides
Pcsk9 loss of-function genetic variant is associated with pre-diabetes and di...
Pcsk9 loss of-function genetic variant is associated with pre-diabetes and di...
Alirocumab effect on new-onset or worsening diabetes, blood glucose, and HbA1c.
Alirocumab effect on new-onset or worsening diabetes, blood glucose, and HbA1c.
Complaint in hdl v johnson and dent
Complaint in hdl v johnson and dent
Center Scope Fall 2014
Center Scope Fall 2014
Improve it slides
Improve it slides
Circ cardiovasc qual outcomes 2013 sep 6(5) 507 8, figure
Circ cardiovasc qual outcomes 2013 sep 6(5) 507 8, figure
Ph rma principlesforresponsibleclinicaltrialdatasharing
Ph rma principlesforresponsibleclinicaltrialdatasharing
Ema q & a on mipomersen march 2013
Ema q & a on mipomersen march 2013
Ema scientific conclusions and grounds for refusal of mipomersen
Ema scientific conclusions and grounds for refusal of mipomersen
Oxman et al a surrealistic mega analysis of redisorganization theories
Oxman et al a surrealistic mega analysis of redisorganization theories
Glasziou taking healthcare interventions from trial to practice
Glasziou taking healthcare interventions from trial to practice
Ioannidis why science is not necessarily self correcting
Ioannidis why science is not necessarily self correcting
Cer symposium 2012_ioannidis
Cer symposium 2012_ioannidis
Ema q & a on mipomersen
Ema q & a on mipomersen
Involveconference2 121120053215-phpapp02
Involveconference2 121120053215-phpapp02
Recently uploaded
Exclusive Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangal...
Exclusive Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangal...
Sheetaleventcompany
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
Sheetaleventcompany
Chennai ❣️ Call Girl 6378878445 Call Girls in Chennai Escort service book now
Chennai ❣️ Call Girl 6378878445 Call Girls in Chennai Escort service book now
tanudubay92
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
Sheetaleventcompany
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
Sheetaleventcompany
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Cara Menggugurkan Kandungan 087776558899
tongue disease lecture Dr Assadawy legacy
tongue disease lecture Dr Assadawy legacy
DrMohamed Assadawy
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Sheetaleventcompany
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Sheetaleventcompany
Call Girls in Lucknow Just Call 👉👉8630512678 Top Class Call Girl Service Avai...
Call Girls in Lucknow Just Call 👉👉8630512678 Top Class Call Girl Service Avai...
soniyagrag336
💚Reliable Call Girls Chandigarh 💯Niamh 📲🔝8868886958🔝Call Girl In Chandigarh N...
💚Reliable Call Girls Chandigarh 💯Niamh 📲🔝8868886958🔝Call Girl In Chandigarh N...
Sheetaleventcompany
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
Swetaba Besh
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
Sheetaleventcompany
💰Call Girl In Bangalore☎️7304373326💰 Call Girl service in Bangalore☎️Bangalor...
💰Call Girl In Bangalore☎️7304373326💰 Call Girl service in Bangalore☎️Bangalor...
Sheetaleventcompany
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
Sheetaleventcompany
Call Girls in Lucknow Just Call 👉👉 8875999948 Top Class Call Girl Service Ava...
Call Girls in Lucknow Just Call 👉👉 8875999948 Top Class Call Girl Service Ava...
Janvi Singh
❤️Call Girl Service In Chandigarh☎️9814379184☎️ Call Girl in Chandigarh☎️ Cha...
❤️Call Girl Service In Chandigarh☎️9814379184☎️ Call Girl in Chandigarh☎️ Cha...
Sheetaleventcompany
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
Oleg Kshivets
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
dishamehta3332
Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...
Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...
Dipal Arora
Recently uploaded
(20)
Exclusive Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangal...
Exclusive Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangal...
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
Chennai ❣️ Call Girl 6378878445 Call Girls in Chennai Escort service book now
Chennai ❣️ Call Girl 6378878445 Call Girls in Chennai Escort service book now
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
tongue disease lecture Dr Assadawy legacy
tongue disease lecture Dr Assadawy legacy
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Call Girls in Lucknow Just Call 👉👉8630512678 Top Class Call Girl Service Avai...
Call Girls in Lucknow Just Call 👉👉8630512678 Top Class Call Girl Service Avai...
💚Reliable Call Girls Chandigarh 💯Niamh 📲🔝8868886958🔝Call Girl In Chandigarh N...
💚Reliable Call Girls Chandigarh 💯Niamh 📲🔝8868886958🔝Call Girl In Chandigarh N...
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
💰Call Girl In Bangalore☎️7304373326💰 Call Girl service in Bangalore☎️Bangalor...
💰Call Girl In Bangalore☎️7304373326💰 Call Girl service in Bangalore☎️Bangalor...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
Call Girls in Lucknow Just Call 👉👉 8875999948 Top Class Call Girl Service Ava...
Call Girls in Lucknow Just Call 👉👉 8875999948 Top Class Call Girl Service Ava...
❤️Call Girl Service In Chandigarh☎️9814379184☎️ Call Girl in Chandigarh☎️ Cha...
❤️Call Girl Service In Chandigarh☎️9814379184☎️ Call Girl in Chandigarh☎️ Cha...
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...
Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...
Rutherford slide
1.
Reduction of LDL-C
with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD): Interim Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial • Background: Heterozygous familial • Results: At week 12, percent change in LDL-C levels hypercholesterolemia (HeFH) is a common genetic were -43% in the 350 mg AMG145 group, -55% in the disorder that causes many patients not to reach LDL-C 420 mg AMG145 group and an increase of 1% in the treatment goals, even with statin therapy. Plasma placebo group. No serious treatment-related adverse proprotein convertase subtilisin/kexin type 9 (PCSK9) events occurred. binds LDL receptors, therefore increasing levels of LDL- • Conclusion: AMG145 may provide effective additional C in the blood. Phase 1 studies of a human monoclonal LDL-C lowering treatment in HeFH patients on intensive antibody to PCSK9, AMG145, have shown tolerance statin therapy. and effectiveness in lowering LDL-C. • Purpose: To assess the effectiveness and safety of Percent of Patients Treated to LDL-C Goal at Week 12 AMG145 in patients with HeFH. Treatment LDL-C < 100 LDL-C < 70 • Methods: In this 12-week, randomized, double-blind, mg/dL mg/dL placebo-controlled study, 167 patients were 350 mg AMG145 70% 44% randomized to one of 3 treatments: 350 mg of AMG145, 420 mg of AMG145 or placebo administered 420 mg AMG145 89% 65% subcutaneously every 4 weeks. Primary endpoint was percent change in LDL-C levels from baseline to 12 Placebo 2% 0% weeks. Presented by: Raal F, AHA Scientific Sessions, Los Angeles © 2012, American Heart Association. All rights reserved.
Download now